Tech Company M&A Transactions

Ilypsa Acquisition

Ilypsa was purchased by Amgen. The transaction was announced on 6/5/2007. The companies indicated that total deal value was $420 million.

Transaction Overview

Company Name
Acquired By
Announced On
6/5/2007
Transaction Type
M&A
Amount
$420,000,000
M&A Terms
The acquisition was paid for with all cash.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3406 Central Expressway
Santa Clara, CA 95051
USA
Email Address
Not Recorded
Overview
Ilypsa, Inc. is a biopharmaceutical company focused on developing a proprietary pipeline of novel non-absorbed polymeric drugs for important therapeutic applications.
Profile
Ilypsa LinkedIn Company Profile
Social Media
Ilypsa Company Twitter Account
Company News
Ilypsa News
Facebook
Ilypsa on Facebook
YouTube
Ilypsa on YouTube

Management Team

Title
Name
Email & Social
Chairman
Scott Rocklage
  Scott Rocklage LinkedIn Profile  Scott Rocklage Twitter Account  Scott Rocklage News  Scott Rocklage on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/5/2007: Mobicious venture capital transaction
Next: 6/5/2007: Storwize venture capital transaction

 

Share this article

 


About Database of VC Transactions

We record funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary